BACKGROUND: Surgery followed by chemotherapy is the primary modality of cure for patients with resectable pancreatic cancer but is associated with significant morbidity. The aim of the present study was to evaluate the role of cardiopulmonary exercise testing (CPET) in predicting post-operative adverse events and fitness for chemotherapy after major pancreatic surgery. METHODS: Patients who underwent a pancreaticoduodenectomy or total pancreatectomy for pancreatic head lesions and had undergone pre-operative CPET were included in this retrospective study. Data on patient demographics, comorbidity and results of pre-operative evaluation were collected. Post-operative adverse events, hospital stay and receipt of adjuvant therapy were outcome measures. RESULTS: One hundred patients were included. Patients with an anaerobic threshold less than 10 ml/kg/min had a significantly greater incidence of a post-operative pancreatic fistula [International Study Group for Pancreatic Surgery (ISGPS) Grades A-C, 35.4% versus 16%, P = 0.028] and major intra-abdominal abscesses [Clavien-Dindo (CD) Grades III-V, 22.4% versus 7.8%, P = 0.042] and were less likely to receive adjuvant therapy [hazard ratio (HR) 6.30, 95% confidence interval (CI) 1.25-31.75, P = 0.026]. A low anaerobic threshold was also associated with a prolonged hospital stay (median 20 versus 14 days, P = 0.005) but not with other adverse events. DISCUSSION: CPET predicts a post-operative pancreatic fistula, major intra-abdominal abscesses as well as length of hospital stay after major pancreatic surgery. Patients with a low anaerobic threshold are less likely to receive adjuvant therapy.
BACKGROUND: Surgery followed by chemotherapy is the primary modality of cure for patients with resectable pancreatic cancer but is associated with significant morbidity. The aim of the present study was to evaluate the role of cardiopulmonary exercise testing (CPET) in predicting post-operative adverse events and fitness for chemotherapy after major pancreatic surgery. METHODS:Patients who underwent a pancreaticoduodenectomy or total pancreatectomy for pancreatic head lesions and had undergone pre-operative CPET were included in this retrospective study. Data on patient demographics, comorbidity and results of pre-operative evaluation were collected. Post-operative adverse events, hospital stay and receipt of adjuvant therapy were outcome measures. RESULTS: One hundred patients were included. Patients with an anaerobic threshold less than 10 ml/kg/min had a significantly greater incidence of a post-operative pancreatic fistula [International Study Group for Pancreatic Surgery (ISGPS) Grades A-C, 35.4% versus 16%, P = 0.028] and major intra-abdominal abscesses [Clavien-Dindo (CD) Grades III-V, 22.4% versus 7.8%, P = 0.042] and were less likely to receive adjuvant therapy [hazard ratio (HR) 6.30, 95% confidence interval (CI) 1.25-31.75, P = 0.026]. A low anaerobic threshold was also associated with a prolonged hospital stay (median 20 versus 14 days, P = 0.005) but not with other adverse events. DISCUSSION: CPET predicts a post-operative pancreatic fistula, major intra-abdominal abscesses as well as length of hospital stay after major pancreatic surgery. Patients with a low anaerobic threshold are less likely to receive adjuvant therapy.
Authors: Jordan M Winter; John L Cameron; Kurtis A Campbell; Meghan A Arnold; David C Chang; Joann Coleman; Mary B Hodgin; Patricia K Sauter; Ralph H Hruban; Taylor S Riall; Richard D Schulick; Michael A Choti; Keith D Lillemoe; Charles J Yeo Journal: J Gastrointest Surg Date: 2006-11 Impact factor: 3.452
Authors: Hemant M Kocher; Paris P Tekkis; Palepu Gopal; Ameet G Patel; Simon Cottam; Irving S Benjamin Journal: World J Gastroenterol Date: 2005-04-28 Impact factor: 5.742
Authors: Peter A McCullough; Michael J Gallagher; Adam T Dejong; Keisha R Sandberg; Justin E Trivax; Daniel Alexander; Gopi Kasturi; Syed M A Jafri; Kevin R Krause; David L Chengelis; Jason Moy; Barry A Franklin Journal: Chest Date: 2006-08 Impact factor: 9.410
Authors: Skye C Mayo; Marta M Gilson; Joseph M Herman; John L Cameron; Hari Nathan; Barish H Edil; Michael A Choti; Richard D Schulick; Christopher L Wolfgang; Timothy M Pawlik Journal: J Am Coll Surg Date: 2011-11-04 Impact factor: 6.113
Authors: Martin A Makary; Jordan M Winter; John L Cameron; Kurtis A Campbell; David Chang; Steven C Cunningham; Taylor S Riall; Charles J Yeo Journal: J Gastrointest Surg Date: 2006-03 Impact factor: 3.452
Authors: F Ausania; C P Snowden; J M Prentis; L R Holmes; B C Jaques; S A White; J J French; D M Manas; R M Charnley Journal: Br J Surg Date: 2012-07-24 Impact factor: 6.939
Authors: A Feldheiser; O Aziz; G Baldini; B P B W Cox; K C H Fearon; L S Feldman; T J Gan; R H Kennedy; O Ljungqvist; D N Lobo; T Miller; F F Radtke; T Ruiz Garces; T Schricker; M J Scott; J K Thacker; L M Ytrebø; F Carli Journal: Acta Anaesthesiol Scand Date: 2015-10-30 Impact factor: 2.105
Authors: Annefleur E M Berkel; Bart C Bongers; Marie-Janne S van Kamp; Hayke Kotte; Paul Weltevreden; Frans H C de Jongh; Michiel M M Eijsvogel; A N Machteld Wymenga; Marloes Bigirwamungu-Bargeman; Job van der Palen; Marc J van Det; Nico L U van Meeteren; Joost M Klaase Journal: BMC Gastroenterol Date: 2018-02-21 Impact factor: 3.067
Authors: Neil Patel; Arfon G Powell; Jenni R Wheat; Christopher Brown; Ian R Appadurai; Richard G Davies; Damian M Bailey; Wyn G Lewis Journal: Physiol Rep Date: 2019-07
Authors: Daniel Steffens; Hilmy Ismail; Linda Denehy; Paula R Beckenkamp; Michael Solomon; Cherry Koh; Jenna Bartyn; Neil Pillinger Journal: Ann Surg Oncol Date: 2021-06-08 Impact factor: 5.344
Authors: Sarah A Vermillion; Alston James; Robert D Dorrell; Peter Brubaker; Shannon L Mihalko; Adrienne R Hill; Clancy J Clark Journal: Syst Rev Date: 2018-07-24